Valneva lifts EMA’s temporary restriction on use of chikungunya vaccine IXCHIQ in elderly
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
Organization to provide vaccinations & treatments for several monsoon related diseases and illnesses across all 102 clinics
States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
The grants are expected to be received over the next three years, commencing March 2022
Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil
Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis
Subscribe To Our Newsletter & Stay Updated